Danaher Corporation $DHR Stock Position Lowered by LaFleur & Godfrey LLC

LaFleur & Godfrey LLC decreased its position in Danaher Corporation (NYSE:DHRFree Report) by 28.7% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 18,642 shares of the conglomerate’s stock after selling 7,518 shares during the period. LaFleur & Godfrey LLC’s holdings in Danaher were worth $3,696,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in DHR. Norges Bank acquired a new stake in shares of Danaher in the second quarter worth $1,979,503,000. Viking Global Investors LP lifted its stake in Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after acquiring an additional 2,455,994 shares in the last quarter. Generation Investment Management LLP boosted its position in Danaher by 56.2% during the 2nd quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock worth $980,914,000 after acquiring an additional 1,787,522 shares during the period. Primecap Management Co. CA grew its stake in Danaher by 924.2% during the 2nd quarter. Primecap Management Co. CA now owns 1,239,320 shares of the conglomerate’s stock valued at $244,815,000 after acquiring an additional 1,118,318 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Danaher by 1.3% in the 2nd quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock valued at $12,004,424,000 after purchasing an additional 788,499 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 11.20% of the stock is owned by insiders.

Danaher Trading Down 0.8%

Shares of NYSE:DHR opened at $209.56 on Monday. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $148.02 billion, a PE ratio of 41.58, a P/E/G ratio of 2.83 and a beta of 0.91. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $242.80. The firm has a fifty day moving average price of $226.85 and a 200 day moving average price of $216.03.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue was up 4.6% compared to the same quarter last year. During the same period last year, the company earned $2.14 earnings per share. Analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s payout ratio is 25.40%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Jefferies Financial Group raised their price target on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. TD Cowen reissued a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. KeyCorp restated an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Argus set a $265.00 price target on shares of Danaher in a research note on Wednesday, January 14th. Finally, The Goldman Sachs Group reduced their price objective on Danaher from $270.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 29th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

View Our Latest Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.